Grab second shot at Hikma
The profit warning fired by Hikma Pharmaceuticals (HIK) on 3 August creates a buying opportunity at the FTSE 100 drug-maker.Delayed product launches and litigation costs have forced management to lower profit expectations for its...
11 August 2016
